APA (7th ed.) Citation

A, L., M, L., K, A., A, P., U, G., S, S., . . . G, S. (2026). Recurrence-free survival is prolonged in high-grade serous ovarian cancer with high PD-L1 expression. BMC cancer. https://doi.org/10.1186/s12885-026-16406-3

Chicago Style (17th ed.) Citation

A, Lalos, Lovrinovic M, Andersen K, Posabella A, Güth U, Stadlmann S, Delko T, Droeser RA, and Singer G. "Recurrence-free Survival Is Prolonged in High-grade Serous Ovarian Cancer with High PD-L1 Expression." BMC Cancer 2026. https://doi.org/10.1186/s12885-026-16406-3.

MLA (9th ed.) Citation

A, Lalos, et al. "Recurrence-free Survival Is Prolonged in High-grade Serous Ovarian Cancer with High PD-L1 Expression." BMC Cancer, 2026, https://doi.org/10.1186/s12885-026-16406-3.